IL-12 targeting could open pathways for new Alzheimer’s treatments

Researchers from Charité – Universitätsmedizin Berlin and the Max Delbrück Center have detailed the precise mechanism through which the inflammatory signaling molecule IL-12 contributes to Alzheimer’s disease.

USC receives $6 million grant for pioneering glioblastoma gene therapy

The California Institute for Regenerative Medicine has awarded a $6 million grant to USC investigators pioneering a new first-of-its-kind genetic therapy for glioblastoma, a severe

February 4, 2025

U.S. School-Entry Vaccination Rates Fall as Exemptions Keep Rising

U.S. kindergarten vaccination rates dipped last year and the proportion of children with exemptions rose to an all-time high, according to federal data posted Wednesday.

October 4, 2024

POLARIS(qb) and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service – Biotech Investments

Syntekabio Inc. POLARIS(qb) and Syntekabio sign MOU for Collaborative AI and Quantum-powered Drug Development Service 31-Aug-2023 / 16:30 CET/CEST The issuer is solely responsible for

September 1, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.